HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2014 | $2.26 K |
2015 | --- |
Total: | $2.26 K |
Period | Weight, tons. |
---|---|
2014 | 0.002 |
2015 | --- |
Total: | 0.002 |
Group product | 2014 | 2015 | Ch. | ∑ (2014-2015) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | --- | --- | --- | --- | 0% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $2.26 K | --- | 100% | $2.26 K | 100% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $2.26 K | --- | $2.26 K |
№ | Country | ∑ (2014-2015) | Ratio |
---|---|---|---|
1 | Slovenia | $414 M | 20.1% |
2 | Hungary | $408 M | 19.8% |
3 | Germany | $266 M | 12.9% |
4 | Netherlands | $153 M | 7.4% |
5 | Poland | $152 M | 7.4% |
6 | India | $79.4 M | 3.9% |
7 | Romania | $74.9 M | 3.6% |
8 | France | $55.3 M | 2.7% |
9 | United States | $54 M | 2.6% |
10 | Latvia | $40.9 M | 2% |
11 | Belarus | $34.5 M | 1.7% |
12 | Austria | $32.9 M | 1.6% |
13 | Ukraine | $31.6 M | 1.5% |
14 | Italy | $25.9 M | 1.3% |
15 | Croatia | $25.9 M | 1.3% |
... | ... | ... | ... |
54 | Monaco | $19.3 K | 0% |
55 | Indonesia | $18.2 K | 0% |
56 | Taiwan | $2.26 K | 0% |
57 | Australia | $796 | 0% |
58 | Norway | $147 | 0% |
... | ... | ... | ... |
The total for all countries: | $2.06 B | 100% |
№ | Region | ∑ (2014-2015) | Ratio |
---|---|---|---|
1 | Moskva | $6.5 M | 83.3% |
2 | Bryanskaya oblast | $1.3 M | 16.3% |
3 | Sankt-Peterburg | $18.2 K | 0.2% |
4 | Irkutskaya oblast | $9.54 K | 0.1% |
5 | Moskovskaya oblast | $2.26 K | 0% |
6 | Vladimirskaya oblast | $1 | 0% |
By all regions: | $7.8 M | 100% |